Document is current

Any future updates will be listed below

Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis

Crossref DOI link: https://doi.org/10.1007/s40262-016-0419-y

Published Online: 2016-06-06

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark